500
Which of the following roles is the nurse responsible for in the development of new and investigational drugs? A. Selecting patients to participate in Phase I studies B. Identifying patients who are receiving placebo drugs during Phase III studies C. Monitoring for and reporting any adverse effects noted during Phase IV studies D. Informing patients of the specific drug they are receiving during the double-blind, placebo-controlled phase of the study
What is C. Monitoring for and reporting any adverse effects noted during Phase IV studies